Related Experiment Video
Updated: Mar 28, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Estimating the in-vivo HIV template switching and recombination rate
Deborah Cromer1, Andrew J Grimm, Timothy E Schlub
1aComplex Systems in Biology Group, Centre for Vascular Research, University of New South Wales, KensingtonbInfection Analytics Program, Kirby Institute, University of New South WalescSchool of Public Health, Sydney University, Camperdown, New South WalesdSchool of Medicine, Faculty of Health, Deakin UniversityeCSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Background:
HIV recombination has been estimated in vitro using a variety of approaches, and shows a high rate of template switching per reverse transcription event. In-vivo studies of recombination generally measure the accumulation of recombinant strains over time, and thus do not directly estimate a comparable template switching rate.
Method:
To examine whether the estimated in-vitro template switching rate is representative of the rate that occurs during HIV infection in vivo, we adopted a novel approach, analysing single genome sequences from early founder viruses to study the in-vivo template switching rate in the env region of HIV.
Results:
We estimated the in-vivo per cycle template switching rate to be between 0.5 and 1.5/1000 nt, or approximately 5-14 recombination events over the length of the HIV genome.
Conclusion:
The in-vivo estimated template switching rate is close to the in-vitro estimated rate found in primary T lymphocytes but not macrophages, which is consistent with the majority of HIV infection occurring in T lymphocytes.
Related Concept Videos
Size and Structure of Viral Genomes
Retrovirus Life Cycles
Viral Mutations
Viral Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Retroviruses

